Cyndi Clark

  • Vanderbilt University

    Arthritis drug could be first to stop heart valve calcification

    The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis. Today in Circulation, the journal of the American Heart Association, Vanderbilt University researchers published findings that the drug – a monoclonal antibody known as SYN0012 – shows promise in keeping heart valve leaflets… Read More

    Jun. 13, 2017